Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany
Matthias Herpers, Charalabos-Markos Dintsios
| Year of publication: |
2019
|
|---|---|
| Authors: | Herpers, Matthias ; Dintsios, Charalabos-Markos |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 20.2019, 1, p. 45-57
|
| Subject: | IQWiG | Early benefit assessment | Benefit quantification | Dichotomization | Pivotal trials | Statistical validity | Deutschland | Germany | Arzneimittel | Pharmaceuticals | Kosten-Nutzen-Analyse | Cost-benefit analysis |